China (Mainland)
Telaprevir CAS NO.402957-28-2
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T,
- Product Details
Keywords
- Telaprevir
- Incivo
- 402957-28-2
Quick Details
- ProName: Telaprevir
- CasNo: 402957-28-2
- Molecular Formula: C36H53N7O6
- Appearance: White Crystalline Powder
- Application: Pharmaceutical intermediates
- DeliveryTime: Within three or five working days
- PackAge: 1kg/bag,seald package or at customer r...
- Port: China main port
- ProductionCapacity: 10 Metric Ton/Month
- Purity: 99.9%
- Storage: Sealed container
- Transportation: Sealed container at cool&dry place
- LimitNum: 1 Kilogram
- Heavy Metal: Not detected
- Valid Period: 2020-12-15
Superiority
1. Advanced Factory Building and Equipment
2. Competent technical team
3 .Strong R & D support
4,high quality products with high stability
5, Competitive price
5.Customer tailored service
Details
|
Name: Telaprevir |
||
|
CAS No.: |
402957-28-2 |
|
|
Content: |
≥ 99.00% |
|
|
Appearance: |
A white,Crystalline Powder or colorless crystals |
|
|
Formula: |
C36H53N7O6 |
|
|
Molecular Weight |
679.85 |
|
|
Moisture: |
≤0.1% |
|
|
Loss on Drying: |
≤0.2% |
|
|
Residue on ignition: |
≤0.1% |
|
|
Heavy Metals: |
≤10PPM |
|
Telaprevir is a member of a class of antiviral drugs known as protease inhibitors used in the treatment of hepatitis C. Telaprevir is co-developed by Vertex Pharmaceuticals and Johnson & Johnson. Telaprevir has been formulated into tablet dosage form and marketed under the trade name of Incivek and Incivo.
On April 28, 2011, the FDA Antiviral Drugs Advisory Committee voted 18-0 to recommend approval telaprevir for people with genotype 1 chronic hepatitis C. Telaprevir was fully approved for use in the United States in May 2011.
